Back to News
Market Impact: 0.05
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
Source: GlobeNewswire
Healthcare & Biotech
Moleculin Biotech (Nasdaq: MBRX) announced that its pre-recorded presentation for the H.C. Wainwright 28th Annual Global Investment Conference is available on demand. The release contains no new clinical, financial, operational, or guidance information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
MBRX0.10
More News
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
- Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
- Federal budget deficit reaches $2T in first 11 months of fiscal year 2026, CBO reports
- Meet Ottava, J&J's surgical robot leading the healthcare giant into a lucrative new market
- AstraZeneca breast cancer drug fails late-stage trial goal